Welcome to
Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, immunoglobulin’s, biodefense, antidotes and diagnostic tests.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.


Sweden’s ambassador Annika Thunborg attended the VASE conference in Mexico City

2018-07-05

VASE 2018 (2nd International Vaccines Against Shigella and ETEC) in Mexico City gathered scientists, public health professionals, immunization leaders, vaccine industry representatives, international donors, and other experts around the globe to share research and ideas toward making Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines a reality. On-site was also Sweden’s ambassador in Mexico, Annika Thunborg. During the meeting the Ambassador presented Sweden’s strategy […]

We want to raise awareness

2018-06-14

We at Scandinavian Biopharma are very proud to be an active participant in the endeavor to reduce child mortality and morbidity. We want to raise awareness of the leading causes of diarrhea and we are doing everything we can to develop a vaccine that will improve children’s chances of winning the fight against diarrheal disease. […]

New ETVAX® data will be presented during Vaccines Against Shigella and ETEC (VASE) conference in Mexico

2018-06-11

The 2nd International Vaccines Against Shigella and ETEC (VASE) Conference will be held on June 12 to 14, in Mexico City, Mexico. Scientists, public health professionals, immunization leaders, vaccine industry representatives, international donors, and other experts around the globe will gather to share research and ideas toward making Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines a reality. The aim of this collaborative, interactive gathering is […]